Metformin and Aging: A Review
Metformin and Aging: A Review
About this item
Full title
Metformin and Aging: A Review
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Gerontology (Basel), 2019-10, Vol.65 (6), p.581-590
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Metformin is sometimes proposed to be an “anti-aging” drug, based on preclinical experiments with lower-order organisms and numerous retrospective data on beneficial health outcomes for type 2 diabetics. Large prospective, placebo-controlled trials are planned, in pilot stage or running, to find a new use (or indication) for an aging population. As...
Alternative Titles
Full title
Metformin and Aging: A Review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_31522175
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31522175
Other Identifiers
ISSN
0304-324X
E-ISSN
1423-0003
DOI
10.1159/000502257
